Graham K. Cooper - Sep 1, 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 04:05 PM
Previous filing
Jun 17, 2022
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +10.4K $0.00 10.4K Sep 1, 2022 Common Stock 10.4K $55.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.